Selektion zur Peritonektomie mit hyperthermer intraoperativer Chemotherapie (HIPEC) bei Peritonealkarzinose

Background: Cytoreductive peritonectomy with hyperthermic intraoperative chemotherapy (HIPEC) is all established therapy for patients with gastrointestinal, gynaecological metastasised peritoneal carcinomatosis as well as primary peritoneal carcinomatous tumours. Methods: On the basis of a literature review and our personal experience, selection criteria for peritonectomy are discussed. Results: Computed tomography (CT) scans and diagnostic laparoscopy are not sufficient for the diagnosis of peritoneal carcinomatosis. The combination of fluorodeoxyglucose positron emission tomography (FDG-PET) and CT seems to be the most reliable diagnostic imaging method. In our institution, all patients undergo PET/CT prior to peritonectomy. Conclusion: The PET/CT scan may play an important role in forecasting the operability of patients with peritoneal carcinomatosis.